Skip to content

NAQI

Active
Public limited companyfounded 1986active for 40 yearsStadsbeemd 1037, 3545 Halen, BelgiumKBO/BCE: BE 0428.898.564
Summary

NAQI has been active since 1986 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €106,161 and a net result of -€12,551. Equity is shrinking by about 15% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2028. Its solvency ranks better than 13% of 91 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).

Risk analysisFollow ReportCompare
NAQIActiveChecked score 66/100
Risk analysis ReportCompare

Overview

Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21209Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21201
3rd oldest company in Halen, Manufacturing sector1 site
Size
€1.2mtotal assets 2025
Staff
6.3 FTE
Equity
€106,161
Loss
-€12,551
Financial health
66 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.0%
Structure
Parent
Business and Consulting Geyskens · 100%
Holdings
1
2025 accounts filed 31 days late3 of 8 deeds summarised
Why 66raises riskEquity €106,161 (8.5% of total assets)Size: 6.3 FTE, total assets €1.2mLast filed accounts filed 31 days late; 1 of the last 3 latelowers riskFounded in 1986Show the evidence

Checked score

Score 2025
66 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 38% of its sector peers (NACE 21, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 34=
equity 8.5% of total assets
Liquidity 42+7
short-term debt 26.2% · cash 2.0%
Profitability 44-28
return on assets -1.0%
Bankruptcy probability, 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.3% (154 companies, NACE 21, micro)
Last 24 months 11-2024: 0.8%lowest value 12-2024: 0.8%● unchanged vs 11-2024lowest value 01-2025: 0.8%● unchanged vs 12-2024lowest value 02-2025: 0.8%● unchanged vs 01-2025 03-2025: 0.8%● unchanged vs 02-2025 04-2025: 0.8%● unchanged vs 03-2025 05-2025: 0.8%● unchanged vs 04-2025 06-2025: 0.8%● unchanged vs 05-2025 07-2025: 1.1%▲ +0.3 percentage points vs 06-2025 08-2025: 0.8%▼ -0.3 percentage points vs 07-2025 09-2025: 0.8%● unchanged vs 08-2025 10-2025: 0.8%● unchanged vs 09-2025 11-2025: 0.8%● unchanged vs 10-2025 12-2025: 0.8%● unchanged vs 11-2025 01-2026: 0.8%● unchanged vs 12-2025 02-2026: 0.8%● unchanged vs 01-2026 03-2026: 0.8%● unchanged vs 02-2026 04-2026: 0.8%● unchanged vs 03-2026 05-2026: 0.8%● unchanged vs 04-2026 06-2026: 0.9%▲ +0.1 percentage points vs 05-2026 07-2026: 0.9%● unchanged vs 06-2026 08-2026: 1.8%▲ +0.9 percentage points vs 07-2026highest value 09-2026: 1.0%▼ -0.8 percentage points vs 08-2026 10-2026: 1.0%● unchanged vs 09-2026
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.89, compared with 1.3 in 2024, above the usual 1.5; short-term debt: 26.2% and cash: 2% of total assets), but 91.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, micro): better than 31% on solvency, 41% on liquidity, 43% on profitability and 37% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Equity €106,161 (8.5% of total assets)
NBB · annual accounts
lowers risk · Founded in 1986
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Size: 6.3 FTE, total assets €1.2m
Companies of this size fail more often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Last filed accounts filed 31 days late; 1 of the last 3 late
NBB · filings
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 13% of 91 sector peers (2025).
NBB · sector comparison
Position among 91 sector peers
Solvency
better than 13%
← weakest strongest →
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
31 days late
2024
3 days early
2023
27 days late
2022
29 days late
2021
26 days late
2020
31 days late
2019
69 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 30 days after the deadline; the sector median (NACE 21) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Resignations: Edgard Geyskens (director) and Margareta…Appointments: Nik Geyskens (director) and…

Key points

  • Caution: Among the weakest 13% on equitysector median €4.9m · 91 companies €106,161 View
  • Controlled by Business and Consulting Geyskens 100% View
  • Flemish supportawarded from 2022 to 2025 €124,780 View

By topic

Financials

Financial year
2025
Total assets
€1.2m
Loss
-€12,551
Solvency
8.5%
Total assets▼ 0.1%
Net result
20182025
Go to Financials

Board & ownership

Board
2 members
Parent
Business and Consulting Geyskens · 100%
  • GEYSKENS KatrienManaging director
  • Nik GeyskensDirector
Go to Board & ownership

Timeline

Events
47
Since
1988
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €100,000
  2. 27-08-2024Annual accounts filed
  3. 31-12-2023Back to profit
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21209
Founded
15-05-1986
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
35
Annual meeting
First Monday of June at 11:00
Purpose
“De vervaardiging in alle stadia van afwerking van alle hygiënische producten voor medisch…” (deed in Dutch)
Go to Articles of association

Key facts about NAQI

What is the company number of NAQI?
0428.898.564. In Belgium the VAT number is the company number with BE in front: BE 0428.898.564.
Where is NAQI based?
The registered office is at Stadsbeemd 1037, 3545 Halen.Company details
What does NAQI do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209).
What is the legal form of NAQI?
Public limited company (NV).
When was NAQI founded?
On 15-05-1986.
Is NAQI still active?
Yes, NAQI is an active enterprise in the KBO register.
How many employees does NAQI have?
On average 6.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of NAQI?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is NAQI profitable?
In financial year 2025, NAQI made a loss of €12,551.
Where can I find the annual accounts of NAQI?
NAQI filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NAQI due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to NAQI

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure